New biodegradable pressure sensor could transform the monitoring of high-risk medical conditions

By Catherine Sturman
Engineers at the University of Connecticut have been behind the development of a new biodegradable pressure sensor, which will support the ongoing manag...

Engineers at the University of Connecticut have been behind the development of a new biodegradable pressure sensor, which will support the ongoing management of long-term, high-risk conditions, such as chronic lung disease.

Showcases in UConn’s digital issue, Proceedings of the National Academy of Sciences, the research team have highlighted that the biodegradable sensor has gained the approval of the US Food and Drug Administration (FDA) and the group are now waiting for a patent application be approved.

Now able to be used in a number of surgeries. Its flexible structure will also enable the sensor to become less invasive than traditional sensors, and lower potential risks of infection.

"Medical sensors are often implanted directly into soft tissues and organs. Taking them out can cause additional damage. We knew that if we could develop a sensor that didn't require surgery to take it out, that would be really significant," explained Thanh Duc Nguyen, Assistant Professor of Mechanical and Biomedical Engineering in the Institute of Regenerative Engineering at UConn Health and the Institute of Materials Science.

See also

"We are very excited because this is the first time these biocompatible materials have been used in this way.”

Releasing electrical charges upon the application of pressure (known as the piezoelectric effect), where signals can be analysed by medical professionals, the sensor can also be applied within the areas of tissue regeneration.

"There are many applications for this sensor," observes Nguyen. "Let's say the sensor is implanted in the brain. We can use biodegradable wires and put the accompanying non-degradable electronics far away from the delicate brain tissue, such as under the skin behind the ear, similar to a cochlear implant. Then it would just require a minor treatment to remove the electronics without worrying about the sensor being in direct contact with soft brain tissue."

Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML